These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23388458)

  • 21. Mechanistic Insights of Vitamin D Anticancer Effects.
    Ma Y; Johnson CS; Trump DL
    Vitam Horm; 2016; 100():395-431. PubMed ID: 26827961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
    Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1.
    McGuire TF; Trump DL; Johnson CS
    J Biol Chem; 2001 Jul; 276(28):26365-73. PubMed ID: 11331275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
    Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
    J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Goniothalamin induces cell cycle arrest and apoptosis in H400 human oral squamous cell carcinoma: A caspase-dependent mitochondrial-mediated pathway with downregulation of NF-κβ.
    Li LK; Rola AS; Kaid FA; Ali AM; Alabsi AM
    Arch Oral Biol; 2016 Apr; 64():28-38. PubMed ID: 26752226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,25-Dihydroxyvitamin D
    Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
    Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
    Chiang KC; Yeh CN; Chen HY; Lee JM; Juang HH; Chen MF; Takano M; Kittaka A; Chen TC
    Steroids; 2011 Dec; 76(13):1513-9. PubMed ID: 21888924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
    Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ
    Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer activity of VDR-coregulator inhibitor PS121912.
    Sidhu PS; Teske K; Feleke B; Yuan NY; Guthrie ML; Fernstrum GB; Vyas ND; Han L; Preston J; Bogart JW; Silvaggi NR; Cook JM; Singh RK; Bikle DD; Arnold LA
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):787-98. PubMed ID: 25107568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered Vitamin D receptor-coactivator interactions reflect superagonism of Vitamin D analogs.
    Eelen G; Verlinden L; Van Camp M; Claessens F; De Clercq P; Vandewalle M; Bouillon R; Verstuyf A
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):65-8. PubMed ID: 16039117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.
    Costa PLF; França MM; Katayama ML; Carneiro ET; Martin RM; Folgueira MAK; Latronico AC; Ferraz-de-Souza B
    Cells; 2019 Apr; 8(4):. PubMed ID: 30959822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.
    Valrance ME; Brunet AH; Welsh J
    Endocrinology; 2007 Oct; 148(10):4887-94. PubMed ID: 17628009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma.
    Prudencio J; Akutsu N; Benlimame N; Wang T; Bastien Y; Lin R; Black MJ; Alaoui-Jamali MA; White JH
    J Natl Cancer Inst; 2001 May; 93(10):745-53. PubMed ID: 11353784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
    Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
    Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.
    Chen-Deutsch X; Studzinski GP
    Cell Cycle; 2012 Apr; 11(7):1364-73. PubMed ID: 22421156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids.
    Lamblin M; Dabbas B; Spingarn R; Mendoza-Sanchez R; Wang TT; An BS; Huang DC; Kremer R; White JH; Gleason JL
    Bioorg Med Chem; 2010 Jun; 18(11):4119-37. PubMed ID: 20452225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.